The American Society for Radiation Oncology (ASTRO) issued the following statement from ASTRO Board of Directors Chair Laura A. Dawson, MD, FASTRO, in response to the recent final rule from the Centers for Medicare and Medicaid Services' (CMS) that indefinitely delays the start of an alternative payment model for radiation oncology (the RO Model)

Getty Images


August 29, 2022 — The American Society for Radiation Oncology (ASTRO) issued the following statement from ASTRO Board of Directors Chair Laura A. Dawson, MD, FASTRO, in response to the recent final rule from the Centers for Medicare and Medicaid Services' (CMS) that indefinitely delays the start of an alternative payment model for radiation oncology (the RO Model): 

“The Centers for Medicare and Medicaid Services (CMS) today finalized an indefinite delay for the Radiation Oncology Model. ASTRO continues to believe that episodic payments will improve access and quality, advance health equity and reduce costs in cancer care. We hope that this official delay provides an opportunity for CMS to work with stakeholders on a new value-based reimbursement structure for radiation therapy. 

Fair and stable Medicare payments are essential to support modern cancer care, especially as clinics face rising inflation costs. We are optimistic that CMS will work more closely with the radiation oncology community on a reformed push for episodic payments.” 

In June, ASTRO submitted comments to CMS that summarized longstanding concerns from the radiation oncology community and bipartisan members of Congress about the model’s emphasis on cost savings over treatment quality. CMS estimated that the RO Model would create $150 million in cuts to radiation oncology, compounding the inflation- and utilization-adjusted 27% drop in Medicare reimbursement for radiation therapy services incurred over the past decade. The letter also outlined reforms to the RO Model that would foster successful participation from physicians and generate substantial saving for the Medicare program. 

ASTRO currently is developing a new proposal for an alternative payment model to share with stakeholders later this year. In addition to an emphasis on episodic payments, the new proposal will emphasize ways to help patients from economically and socially marginalized groups access and complete radiation treatments. 

For more information: www.astro.org 

Find more ASTRO22 information here 

Related CMS Content:    

Radiation Oncologists Applaud Biden-Harris Administration's Renewed Commitment to Cancer Moonshot    

Racial/Ethnic Disparities Persist in Lung Cancer Screening Eligibility    

Primary Lung Cancers Detected by LDCT are at Lower Risk of Brain Metastases    

Physician and Patient Groups Call On CMS to Update Medicare Lung Cancer Screening Coverage    

USPSTF Expands Lung Cancer Screening Eligibility Thresholds     

Low-dose CT for Lung Cancer Screening: Benefit Outweighs Potential Harm    

Physician and Patient Groups Call On CMS to Update Medicare Lung Cancer Screening Coverage 

 


Related Content

News | Radiology Education

May 24, 2024 — The American Society of Radiologic Technologists (ASRT) has announced that its ASRT Foundation has ...

Time May 24, 2024
arrow
News | Enterprise Imaging

May 24, 2024 — International medical imaging IT and cybersecurity company Sectra’s enterprise imaging solution has been ...

Time May 24, 2024
arrow
News | Artificial Intelligence

May 23, 2024 — NewVue.ai, born from the radiology technology pioneers behind peerVue and recognized as a trailblazer in ...

Time May 23, 2024
arrow
News | Radiation Therapy

May 23, 2024 — RaySearch Laboratories AB and C-RAD announced a collaboration agreement, aiming at jointly developing ...

Time May 23, 2024
arrow
News | FDA

May 22, 2024 — The U.S. Food and Drug Administration (FDA) has issued a recall of the Hologic Inc. BioZorb marker due to ...

Time May 22, 2024
arrow
News | Artificial Intelligence

May 22, 2024 — Lunit, a provider of Artificial intelligence (AI)-powered solutions for cancer diagnostics and ...

Time May 22, 2024
arrow
News | Artificial Intelligence

May 22, 2024 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, recently ...

Time May 22, 2024
arrow
News | Oncology Information Management Systems (OIMS)

May 21, 2024 — RaySearch Laboratories AB announced that the oncology information system RayCare* 2024A has been ...

Time May 21, 2024
arrow
News | Proton Therapy

May 21, 2024 — IBA, a world leader in particle accelerator technology, announced that it has signed a contract with the ...

Time May 21, 2024
arrow
News | Radiology Business

May 20, 2024 — Associated Medical Professionals of NY (A.M.P.) announced that internationally recognized radiation ...

Time May 20, 2024
arrow
Subscribe Now